Massachusetts Financial Services
HRMY icon

Massachusetts Financial Services’s Harmony Biosciences HRMY Stock Holding History

Massachusetts Financial Services’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.56M Sell
270,013
-271,268
-50% -$8.89M ﹤0.01% 740
2025
Q4 		$20.3M Sell
541,281
-29,258
-5% -$962K 0.01% 643
2025
Q3 		$15.7M Sell
570,539
-73,991
-11% -$2.55M ﹤0.01% 659
2025
Q2 		$20.4M Sell
644,530
-109,017
-14% -$3.51M 0.01% 614
2025
Q1 		$25M Sell
753,547
-76,073
-9% -$2.73M 0.01% 571
2024
Q4 		$28.5M Buy
829,620
+169,229
+26% +$5.81M 0.01% 552
2024
Q3 		$26.4M Buy
660,391
+140,690
+27% +$4.94M 0.01% 560
2024
Q2 		$15.7M Buy
519,701
+13,547
+3% +$407K ﹤0.01% 600
2024
Q1 		$17M Sell
506,154
-2,478
-0.5% -$79.5K 0.01% 595
2023
Q4 		$16.4M Buy
508,632
+434
+0.1% +$12.1K 0.01% 589
2023
Q3 		$16.7M Buy
508,198
+864
+0.2% +$30K 0.01% 583
2023
Q2 		$17.9M Buy
507,334
+96,397
+23% +$3.33M 0.01% 570
2023
Q1 		$13.4M Buy
410,937
+70,834
+21% +$3.23M ﹤0.01% 591
2022
Q4 		$18.7M Sell
340,103
-75,348
-18% -$4.14M 0.01% 556
2022
Q3 		$18.4M Buy
415,451
+28,539
+7% +$1.39M 0.01% 561
2022
Q2 		$18.9M Sell
386,912
-2,848
-0.7% -$128K 0.01% 563
2022
Q1 		$19M Sell
389,760
-170,108
-30% -$6.94M 0.01% 587
2021
Q4 		$23.9M Sell
559,868
-107,916
-16% -$4.3M 0.01% 590
2021
Q3 		$25.6M Sell
667,784
-8,836
-1% -$285K 0.01% 588
2021
Q2 		$19.1M Buy
676,620
+71,755
+12% +$2.15M 0.01% 620
2021
Q1 		$20M Buy
604,865
+91,295
+18% +$3.2M 0.01% 604
2020
Q4 		$18.6M Buy
513,570
+183,902
+56% +$7.42M 0.01% 599
2020
Q3 		$11.2M Buy
+329,668
New +$12M ﹤0.01% 624

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Massachusetts Financial Services's HRMY Position: Q1 2026 in Review

Massachusetts Financial Services reduced its Harmony Biosciences (HRMY) stake by 50% in Q1 2026, selling an estimated $8.89M and leaving 270,013 shares worth $7.56M. The position accounts for ﹤0.01% of the portfolio, ranked #740.

Massachusetts Financial Services first reported a position in HRMY in Q3 2020 and has held it in 23 quarters since. The position peaked at $28.5M in Q4 2024. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Massachusetts Financial Services held 270,013 shares of Harmony Biosciences worth $7.56M as of Q1 2026.
  • Massachusetts Financial Services sold 271,268 Harmony Biosciences shares in Q1 2026, an estimated $8.89M.
  • Harmony Biosciences made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q1 2026, its #740 holding.
  • Massachusetts Financial Services first reported a position in Harmony Biosciences in Q3 2020 and has held it in 23 quarters since.
  • Massachusetts Financial Services's Harmony Biosciences position peaked at $28.5M in Q4 2024.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.